Non-muscle-invasive bladder cancer: a vision for the future
Open Access
- 7 February 2017
- journal article
- review article
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 51 (2), 87-94
- https://doi.org/10.1080/21681805.2017.1283359
Abstract
The management of non-muscle-invasive bladder cancer (NMIBC) has evolved from the first reports on bladder endoscopy and transurethral resection to the introduction of adjuvant intravesical treatment. However, disease recurrence and progression remain an ongoing risk, placing a heavy burden on healthcare resources and on patients’ quality of life. Deeper understanding of the molecular basis of the disease and developments in optics, lasers and computer science are already offering opportunities to revolutionize care and improve long-term prognosis. This article discusses developments likely to cause a paradigm shift towards the delivery of personalized care and reduced burden of disease in NMIBC.Keywords
Funding Information
- Photocure ASA, Oslo, Norway
This publication has 54 references indexed in Scilit:
- Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO GuidelineJournal of Urology, 2016
- Economic Burden of Bladder Cancer Across the European UnionEuropean Urology, 2016
- Urinary Biomarkers for Diagnosis of Bladder CancerAnnals of Internal Medicine, 2015
- Bladder cancer detection in patients with gross haematuria: Computed tomography urography with enhancement-triggered scan versus flexible cystoscopyScandinavian Journal of Urology, 2015
- Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversityNature Reviews Cancer, 2014
- Detecting DNA Methylation of the BCL2, CDKN2A and NID2 Genes in Urine Using a Nested Methylation Specific Polymerase Chain Reaction Assay to Predict Bladder CancerJournal of Urology, 2012
- A Multi-Analyte Assay for the Non-Invasive Detection of Bladder CancerPLOS ONE, 2012
- Delivering affordable cancer care in high-income countriesThe Lancet Oncology, 2011
- Bladder Cancer–Associated Gene Expression Signatures Identified by Profiling of Exfoliated UrotheliaCancer Epidemiology, Biomarkers & Prevention, 2009
- Urothelial tumorigenesis: a tale of divergent pathwaysNature Reviews Cancer, 2005